Skip to main content
Premium Trial:

Request an Annual Quote

VIMRX, Columbia Univ. Agree to Collaborate on New Cancer Targets


WILMINGTON, Del.--Bioinformatics will be used to develop diagnostic and therapeutic targets under terms of a new agreement between VIMRX Pharmaceuticals here and Columbia University. The development work will be based on two cancer genes, recently identified by scientists at the Columbia Genome Center, that control non-Hodgkin's lymphoma and multiple myeloma.

The agreement grants VIMRX Genomics, a subsidiary of the pharmaceutical company, the rights to the gene licenses and patents developed through the partnership. A spokeswoman for VIMRX said Columbia's four-person bioinformatics team will be used in the target development efforts. "To enhance the commercial potential of these important genes, VIMRX will seek technology strategic alliances with pharmaceutical and/or diagnostic companies to develop a cancer gene package that includes the identified and validated gene target, functional assays, and candidate diagnostic or therapeutic molecules," commented Richard Kouri, president of VIMRX.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.